Transaction #11051 · Form 4 · 0001610717-25-000384
Revolution Medicines, Inc. · Exercise / conversion · Common Stock
Revolution Medicines, Inc. · Transacted November 18, 2025 · Filed November 20, 2025
What does this filing report?
An SEC Form 4 filing for Revolution Medicines, Inc. records an exercise / conversion involving Common Stock on November 18, 2025. The reported quantity was 20,000. The filing date is November 20, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Revolution Medicines, Inc.
- Company CIK
- 0001628171
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 20,000
- Reported price
- 4.09
- Reference value
- 81,800
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 267,863
- Ownership description
- Not reported
- SEC acceptance time
- Nov 20, 2025, 4:23 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- GOLDSMITH MARK A ↗
See Remarks · Director
CIK 0001246842
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.
- F2
- Includes 193,475 restricted stock units.
- F3
- This transaction was executed in multiple trades at prices ranging from $70.00 to $70.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4
- Held by Jonathan Goldsmith Revocable Trust.
- F5
- Reflects the transfer of 15,926 shares.
- F6
- Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
- F7
- Held by Rebecca Goldsmith Revocable Trust.
- F8
- Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Remarks
President and Chief Executive Officer
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.